Recombinant BTLA (Tifcemalimab Biosimilar) anticorps (Biotin)
Aperçu rapide pour Recombinant BTLA (Tifcemalimab Biosimilar) anticorps (Biotin) (ABIN7828960)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Classe de qualité
-
-
Fonction
- Biotinylated Anti-BTLA(tifcemalimab biosimilar) mAb
-
Isotype
- IgG4
-
-
-
-
Commentaires
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Date de péremption
- 12 months
-
-
- BTLA (Tifcemalimab Biosimilar)
-
Autre désignation
- Tifcemalimab Biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
-
Synonyms Target:BTLA,BTLA1,CD272
Synonyms Antibody:Icatolimab,JS-004,JS004,JS 004,JS-4,JS4,JS 4,TAB-004,TAB004,TAB 004,TAB-4,TAB4,TAB 4 -
UniProt
- Q7Z6A9
Antigène
-